Literature DB >> 21068153

Sociodemographic factors and vestibular schwannoma: a Danish nationwide cohort study.

Joachim Schüz1, Marianne Steding-Jessen, Søren Hansen, Sven-Eric Stangerup, Per Cayé-Thomasen, Christoffer Johansen.   

Abstract

Vestibular schwannoma (VS) (or acoustic neuroma) accounts for about 5%-6% of all intracranial tumors; little is known about the etiology. We investigated the association between various sociodemographic indicators and VS in a cohort of 3.26 million Danish residents, with 1087 cases identified in 35 308 974 person-years under risk, with data accrued from 1993 to 2006. Complete ascertainment of cases was ensured by using population-based and clinical cancer registries. Information on sociodemographic indicators was obtained on an annually updated individual level from Statistics Denmark. Log-linear Poisson regression models were used to estimate incidence rate ratios (IRRs). Linear regression models were used to examine the association between sociodemographic indicators and tumor size. We found that IRRs decreased gradually with decreasing level of education, with values of 0.62 (95% CI: 0.49-0.78) for men and 0.62 (95% CI: 0.50-0.77) for women with a basic education compared with a higher education. Similar results were found for disposable income. Marital status was associated with a higher incidence of VS in men but not women; nonmarried men with a basic education had an IRR of 0.34 (95% CI: 0.23-0.50) compared with married men with a higher education. Lower incidence rates were also observed among unemployed or early-retirement pensioners, whereas there were no differences in incidence rates across the broad groups of occupations and across the types of districts. Sociodemographic indicators were not associated with the tumor size. The magnitude of the differences in incidence rates across the groups of different socioeconomic indicators suggests a high potential for earlier diagnosis of VS by improving the awareness of early symptoms.

Entities:  

Mesh:

Year:  2010        PMID: 21068153      PMCID: PMC3018936          DOI: 10.1093/neuonc/noq149

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  25 in total

1.  What is the real incidence of vestibular schwannoma?

Authors:  Mirko Tos; Sven-Eric Stangerup; Per Cayé-Thomasen; Tina Tos; Jens Thomsen
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-02

2.  Clinical experience with vestibular schwannomas: epidemiology, symptomatology, diagnosis, and surgical results.

Authors:  M Tos; S Charabi; J Thomsen
Journal:  Eur Arch Otorhinolaryngol       Date:  1998       Impact factor: 2.503

3.  Prevalence of unsuspected acoustic neuroma found by magnetic resonance imaging.

Authors:  T D Anderson; L A Loevner; D C Bigelow; N Mirza
Journal:  Otolaryngol Head Neck Surg       Date:  2000-05       Impact factor: 3.497

4.  The prevalence of "incidental" acoustic neuroma.

Authors:  Doris Lin; Joseph L Hegarty; Nancy J Fischbein; Robert K Jackler
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2005-03

5.  The Danish Cancer Registry--history, content, quality and use.

Authors:  H H Storm; E V Michelsen; I H Clemmensen; J Pihl
Journal:  Dan Med Bull       Date:  1997-11

Review 6.  Epidemiology, pathogenesis, and genetics of acoustic tumors.

Authors:  M J Lanser; S A Sussman; K Frazer
Journal:  Otolaryngol Clin North Am       Date:  1992-06       Impact factor: 3.346

7.  Increasing annual incidence of vestibular schwannoma and age at diagnosis.

Authors:  Sven-Eric Stangerup; Mirko Tos; Per Caye-Thomasen; Tina Tos; Mads Klokker; Jens Thomsen
Journal:  J Laryngol Otol       Date:  2004-08       Impact factor: 1.469

8.  Cellular telephone use and risk of acoustic neuroma.

Authors:  Helle Collatz Christensen; Joachim Schüz; Michael Kosteljanetz; Hans Skovgaard Poulsen; Jens Thomsen; Christoffer Johansen
Journal:  Am J Epidemiol       Date:  2004-02-01       Impact factor: 4.897

9.  Noise trauma in the aetiology of acoustic neuromas in men in Los Angeles County, 1978-1985.

Authors:  S Preston-Martin; D C Thomas; W E Wright; B E Henderson
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

Review 10.  Risk factors associated with vestibulocochlear nerve schwannoma: systematic review.

Authors:  Ana Paula Corona; Jacqueline Carneiro Oliveira; Fábia Pinheiro Andrade de Souza; Liane Viana Santana; Marco Antônio Vasconcelos Rêgo
Journal:  Braz J Otorhinolaryngol       Date:  2009 Jul-Aug
View more
  6 in total

1.  Does where you live influence how your vestibular schwannoma is managed? Examining geographical differences in vestibular schwannoma treatment across the United States.

Authors:  Matthew L Carlson; Amy E Glasgow; Brandon R Grossardt; Elizabeth B Habermann; Michael J Link
Journal:  J Neurooncol       Date:  2016-06-22       Impact factor: 4.130

2.  Incidence trends of vestibular schwannomas in Denmark, Finland, Norway and Sweden in 1987-2007.

Authors:  S Larjavaara; M Feychting; R Sankila; C Johansen; L Klaeboe; J Schüz; A Auvinen
Journal:  Br J Cancer       Date:  2011-09-06       Impact factor: 7.640

3.  Role of tobacco use in the etiology of acoustic neuroma.

Authors:  Sadie Palmisano; Judith Schwartzbaum; Michaela Prochazka; David Pettersson; Tommy Bergenheim; Rut Florentzson; Henrik Harder; Tiit Mathiesen; Gunnar Nyberg; Peter Siesjö; Maria Feychting
Journal:  Am J Epidemiol       Date:  2012-04-19       Impact factor: 4.897

4.  Vestibular schwannoma appears to be very rare in a region of Sub-Saharan Africa.

Authors:  S Ohaegbulam; O Okwunodulu; C Ndubuisi; W Mezue; M Chikani; S Nkwerem; M Ekuma
Journal:  Surg Neurol Int       Date:  2017-08-01

5.  Socioeconomic inequalities in cancer incidence in Europe: a comprehensive review of population-based epidemiological studies.

Authors:  Ana Mihor; Sonja Tomsic; Tina Zagar; Katarina Lokar; Vesna Zadnik
Journal:  Radiol Oncol       Date:  2020-02-19       Impact factor: 2.991

6.  Association between health insurance status and malignant glioma.

Authors:  Igor Fischer; Hendrik-Jan Mijderwijk; Ulf D Kahlert; Marion Rapp; Michael Sabel; Daniel Hänggi; Hans-Jakob Steiger; Marie-Therese Forster; Marcel A Kamp
Journal:  Neurooncol Pract       Date:  2020-06-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.